Maihle NJ - Search Results

1

Lin28 regulates HER2 and promotes malignancy through multiple mechanisms.

Feng C, Neumeister V, Ma W, Xu J, Lu L, Bordeaux J, Maihle NJ, Rimm DL, Huang Y. Feng C, et al. Among authors: maihle nj. Cell Cycle. 2012 Jul 1;11(13):2486-94. doi: 10.4161/cc.20893. Epub 2012 Jul 1. Cell Cycle. 2012. PMID: 22713243

2

Lin28 regulates BMP4 and functions with Oct4 to affect ovarian tumor microenvironment.

Ma W, Ma J, Xu J, Qiao C, Branscum A, Cardenas A, Baron AT, Schwartz P, Maihle NJ, Huang Y. Ma W, et al. Among authors: maihle nj. Cell Cycle. 2013 Jan 1;12(1):88-97. doi: 10.4161/cc.23028. Epub 2012 Dec 19. Cell Cycle. 2013. PMID: 23255092 Free PMC article.

3

Pluripotency factors Lin28 and Oct4 identify a sub-population of stem cell-like cells in ovarian cancer.

Peng S, Maihle NJ, Huang Y. Peng S, et al. Among authors: maihle nj. Oncogene. 2010 Apr 8;29(14):2153-9. doi: 10.1038/onc.2009.500. Epub 2010 Jan 25. Oncogene. 2010. PMID: 20101213

4

Metformin alters DNA methylation genome-wide via the H19/SAHH axis.

Zhong T, Men Y, Lu L, Geng T, Zhou J, Mitsuhashi A, Shozu M, Maihle NJ, Carmichael GG, Taylor HS, Huang Y. Zhong T, et al. Among authors: maihle nj. Oncogene. 2017 Apr 27;36(17):2345-2354. doi: 10.1038/onc.2016.391. Epub 2016 Oct 24. Oncogene. 2017. PMID: 27775072 Free PMC article.

5

EGFR/HER-targeted therapeutics in ovarian cancer.

Wilken JA, Badri T, Cross S, Raji R, Santin AD, Schwartz P, Branscum AJ, Baron AT, Sakhitab AI, Maihle NJ. Wilken JA, et al. Among authors: maihle nj. Future Med Chem. 2012 Mar;4(4):447-69. doi: 10.4155/fmc.12.11. Future Med Chem. 2012. PMID: 22416774 Free PMC article. Review.

6

Primary trastuzumab resistance: new tricks for an old drug.

Wilken JA, Maihle NJ. Wilken JA, et al. Among authors: maihle nj. Ann N Y Acad Sci. 2010 Oct;1210:53-65. doi: 10.1111/j.1749-6632.2010.05782.x. Ann N Y Acad Sci. 2010. PMID: 20973799 Free PMC article.

7

Trastuzumab-induced HER reprogramming in "resistant" breast carcinoma cells.

Narayan M, Wilken JA, Harris LN, Baron AT, Kimbler KD, Maihle NJ. Narayan M, et al. Among authors: maihle nj. Cancer Res. 2009 Mar 15;69(6):2191-4. doi: 10.1158/0008-5472.CAN-08-1056. Epub 2009 Mar 10. Cancer Res. 2009. PMID: 19276389

8

EGFR isoforms and gene regulation in human endometrial cancer cells.

Albitar L, Pickett G, Morgan M, Wilken JA, Maihle NJ, Leslie KK. Albitar L, et al. Among authors: maihle nj. Mol Cancer. 2010 Jun 25;9:166. doi: 10.1186/1476-4598-9-166. Mol Cancer. 2010. PMID: 20579378 Free PMC article.

9

Shedding of soluble epidermal growth factor receptor (sEGFR) is mediated by a metalloprotease/fibronectin/integrin axis and inhibited by cetuximab.

Wilken JA, Perez-Torres M, Nieves-Alicea R, Cora EM, Christensen TA, Baron AT, Maihle NJ. Wilken JA, et al. Among authors: maihle nj. Biochemistry. 2013 Jul 2;52(26):4531-40. doi: 10.1021/bi400437d. Epub 2013 Jun 21. Biochemistry. 2013. PMID: 23731208

10

Identification of immunoreactive regions of homology between soluble epidermal growth factor receptor and α5-integrin.

Wilken JA, Baron AT, Foty RA, McCormick DJ, Maihle NJ. Wilken JA, et al. Among authors: maihle nj. Biochemistry. 2011 May 24;50(20):4309-21. doi: 10.1021/bi200126j. Epub 2011 Apr 27. Biochemistry. 2011. PMID: 21491912 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

118 results

Search Page